School of Medicine
Showing 101-110 of 139 Results
-
Debarun Patra
Postdoctoral Scholar, Cardiovascular Institute
BioDebarun Patra is a postdoctoral researcher at Stanford Medicine, with a background in inflammation research. His research focuses on metabolic disease modeling and identifying novel therapeutic targets. His current work integrates inflammatory and metabolic diseases (IBD, MASH, and diabetes), using patient-derived iPS cells and primary cells, and employs advanced multi-omics.
-
Prince Allawadhi
Postdoctoral Scholar, Gastroenterology, Hepatology, and Nutrition
BioMy research focuses on immune-stromal crosstalk in pancreatic diseases, with an emphasis on how myofibroblasts and macrophages drive inflammation, fibrosis, and multi-organ dysfunction. By integrating patient-derived organoids, zebrafish models, and multi-omics, I aim to unravel the cellular and molecular mechanisms underlying pancreatic injury and repair. I am developing cutting-edge zebrafish models of exocrine pancreas disorders to uncover novel immuno-fibrotic pathways and accelerate the identification of translational targets for early diagnosis and therapeutic intervention.
-
David A. Relman
Thomas C. and Joan M. Merigan Professor and Professor of Microbiology and Immunology
Current Research and Scholarly InterestsMy investigative program focuses on human-microbe interactions and human microbial ecology, and primarily concerns the ecology of human indigenous microbial communities; a secondary interest concerns the classification of humans with systemic infectious diseases, based on features of genome-wide gene transcript abundance patterns and pther aspects of the host response.
-
Michael J Rosen, MD, MSCI
Stanford University Endowed Professor for Pediatric IBD and Celiac Disease
BioDr. Rosen is a pediatric gastroenterologist and physician scientist who has been devoted to advancing inflammatory bowel disease (IBD) research and care for 25 years. He is the inaugural Stanford University Endowed Professor for Pediatric IBD and Celiac Disease. He is also Director of the Stanford Medicine Children’s Health Center for IBD and Celiac Disease, which has achieved nationally leading clinical outcomes under his direction. Dr. Rosen’s research expertise crosses mucosal immunology and epithelial biology and clinical and translational investigation. His NIH-funded laboratory has demonstrated the protective role for type 2 cytokines in chronic intestinal inflammation and advanced intestinal organoids as a model to study IBD. His clinical research has demonstrated how proactive therapeutic drug monitoring can be incorporated into clinical practice to optimize ant-TNF therapy treatment response. Dr. Rosen led the multicenter ARCH Study, which demonstrated the importance of intensified anti-TNF drug dosing in pediatric acute severe ulcerative colitis. Presently, he is co-principal investigator for the Crohn's & Colitis Foundation’s Cohort for Pediatric Translational and Clinical Research in IBD (CAPTURE IBD) which will advance precision medicine for children with IBD.
After graduating from Duke University, Dr. Rosen attended Harvard Medical School, followed by pediatrics residency at Boston Children’s Hospital and Boston Medical Center. He pursued his pediatric gastroenterology fellowship at Vanderbilt University Medical Center, where he received a Master of Science in Clinical Investigation. He started his faculty career at Vanderbilt and then moved to Cincinnati Children’s Hospital and the University of Cincinnati College of Medicine. There he rose to Medical Director of the Schubert Martin IBD Center and Associate Director for Faculty Development in the Gastroenterology division before moving to Stanford in 2021. Dr. Rosen serves on the editorial board for Inflammatory Bowel Diseases and the National Scientific Advisory Committee for the Crohn’s & Colitis Foundation. Outside of work, Dr. Rosen enjoys spending time with his wife and two children at their activities, watching movies, downhill skiing, and getting outside.
